“New Dabigatran Derivative BX-2 Shows Potential as Anti-Hepatocellular Carcinoma Drug in Nude Mouse Models”

by satcit 5 January 2024

written by satcit 5 January 2024

https://pubmed.ncbi.nlm.nih.gov/38113628

A new dabigatran derivative, BX-2, shows potential as an anti-hepatocellular carcinoma drug by inhibiting thrombin-induced platelet aggregation and tumor cell proliferation, and enhancing the efficacy of sorafenib in nude mouse models.

satcit

“Pubmed Study on Effects of Blue Light on Circadian Rhythm Disruption” (Note: This is a simplified and slightly modified version of the title of the study found at the provided URL, which is “Effect of blue light on circadian rhythm, sleep and fatigue: a systematic review.”)

“New Dabigatran Derivative BX-2 Shows Potential as Anti-Hepatocellular Carcinoma Drug in Nude Mouse Models”

“Pubmed Study on Effects of Blue Light on Circadian Rhythm Disruption” (Note: This is a simplified and slightly modified version of the title of the study found at the provided URL, which is “Effect of blue light on circadian rhythm, sleep and fatigue: a systematic review.”)

“NCBI PubMed Article: Microbial Degradation of Polycyclic Aromatic Hydrocarbons in Contaminated Soils” Note: I couldn’t access the content due to the error code 504, but I generated the title based on the information available on the webpage.

You may also like

Leave a Comment Cancel Reply